Lommatzsch P K
Klin Monbl Augenheilkd. 1979 Nov;175(5):641-50.
A report on 150 patients suffering from retinoblastoma (71 unilateral and 79 bilateral cases) treated between 1960 and 1977. There was a familiar accumulation of retinoblastoma in 8.9% of the bilateral and 5.8% of the unilateral cases. Leukokoria and squint were the most frequent first signs of the tumor. The overall lethality was 12.7% during an average follow up period of 7.8 years. The lethality due to metastases on bilateral cases (8.9%) was as high as that due to unilateral retinoblastomas (9.9%). Spontaneous cure occurred in 2%. The cure rate of unilateral retinoblastomas was 87.3%. The survival rate in bilateral tumor cases 84.8%. The eye with the more advanced tumor was enucleated immediately; irradiation therapy only saved both eyes in one patient. Enucleation of the second eye was necessary in 40.5% of our patients suffering from bilateral retinoblastoma. In 43.8% of all bilateral retinoblastomas destruction of the tumor in the second eye was accomplished and a useful degree of visual acuity was achieved after an average follow-up period of 7.5 years.--The optimum therapeutic procedure depends on the size and position of the retinoblastoma and should be scheduled individually in each patient: photocoagulation, cryocoagulation, 106Ru/ 106Rh-applicator, 60Co-applicators, external beam irradiation (linear accelerator 5 MeV), chemotherapy.
一份关于1960年至1977年间接受治疗的150例视网膜母细胞瘤患者(71例单侧和79例双侧病例)的报告。在双侧病例中,8.9%存在视网膜母细胞瘤家族聚集现象,单侧病例中这一比例为5.8%。白瞳症和斜视是该肿瘤最常见的首发症状。在平均7.8年的随访期内,总体死亡率为12.7%。双侧病例因转移导致的死亡率(8.9%)与单侧视网膜母细胞瘤导致的死亡率(9.9%)一样高。2%的患者出现自发治愈。单侧视网膜母细胞瘤的治愈率为87.3%。双侧肿瘤病例的生存率为84.8%。肿瘤进展更严重的眼睛立即被摘除;放射治疗仅使一名患者的双眼得以保全。在我们患有双侧视网膜母细胞瘤的患者中,40.5%的患者需要摘除第二只眼睛。在所有双侧视网膜母细胞瘤中,43.8%的病例在第二只眼中的肿瘤被消除,平均随访7.5年后获得了有用的视力程度。——最佳治疗方法取决于视网膜母细胞瘤的大小和位置,应针对每位患者单独制定:光凝、冷冻、106Ru/106Rh敷贴器、60Co敷贴器、外照射(直线加速器5 MeV)、化疗。